Kalaris Therapeutics, Inc. · NASDAQ:KLRS
Kalaris Therapeutics, Inc. shareholders
As of Sep 30, 2026, 52 institutions reported holding Kalaris Therapeutics, Inc., 72.4% of its shares. Largest: Samsara Biocapital, LLC, Rtw Investments, LP and Alyeska Investment Group, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Kalaris Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Samsara Biocapital, LLC | 12.9M | 54.1% | no change | Nov 16, 2026 |
| Rtw Investments, LP | 1.3M | 5.5% | no change | Nov 16, 2026 |
| Alyeska Investment Group, L.P. | 473K | 2.0% | −100K | Nov 16, 2026 |
| Vanguard | 379K | 1.6% | −86,410 | Nov 13, 2026 |
| Siren, L.L.C. | 357K | 1.5% | −79,239 | Nov 12, 2026 |
| Ikarian Capital, LLC | 248K | 1.0% | −112K | Nov 16, 2026 |
| Renaissance Technologies | 177K | 0.74% | +27,512 | Nov 12, 2026 |
| Verdad Advisers, LP | 140K | 0.59% | +59,935 | Nov 16, 2026 |
| UBS | 110K | 0.46% | −152K | Nov 10, 2026 |
| Raymond James Financial Inc | 101K | 0.43% | +4,332 | Nov 12, 2026 |